PharmaShots | Incisive News in 3 Shots

Subscribe Now

Actuate Therapeuticsm

Actuate Therapeutics Initiates Randomized Trial of Elraglusib + Folfirinox as 1L Treatment of Advanced Pancreatic Cancer

Actuate Therapeutics Initiates Randomized Trial of Elraglusib + Folfirinox as 1L Treatment of Advanced Pancreatic Cancer

February 8, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us